Stay updated with breaking news from Jeffrey Hackman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Daniella Parra Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA) said it completed a $4.1 million private placement of shares and warrants to existing stockholders. The company said it aims to develop new biologic medicines to improve patient access and convenience. Comera has entered into a registration rights agreement to register the resale of the […]
– Ownership of proprietary sourcing for U.S.-manufactured lead SQore excipients allows for full control over supply chain and greater flexibility to...
'We have people taking two or three different injectable drugs every other week.'
Having patients give themselves injections, when possible, not only saves clinic time and expense, but also spares the patients a trip to the clinic, of course, and often a copay.
- Significant progress in Comera's ongoing research collaboration with Regeneron, a leading U.S. biotechnology company - - Further development of Comera's pipeline candidate CLS-001 (SQ vedolizumab),